Company profile
TORL BioTherapeutics company profile
TORL BioTherapeutics is a clinical-stage biopharmaceutical business focused on creating innovative, antibody-based medicines to improve the lives of cancer patients. They are developing a comprehensive pipeline of innovative preclinical ADCs and mAb in oncologic diseases with high unmet medical needs.
Business identity
- Website
- https://torlbio.com
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Founded
- 2018-01-01, Year
Headquarters
- Headquarters
- Los Angeles, California, United States
- Country code
- US
- Continent
- North America